Stockscreener 앱 받기
89.76
2.26%
-1.99
Transmedics Group Inc 주식(TMDX)의 최신 뉴스
What Could Higher Yields Mean for TransMedics (NASDAQ:TMDX) Now? - Kalkine Media
TransMedics Group Inc (TMDX) Shares Fall 3.3% -- What GF Score o - GuruFocus
Diversify Advisory Services LLC Purchases Shares of 15,872 TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics (TMDX) Outlook: Rises 3.62% to $93.97 on the Day; Trading Range: $89.27 and $98.67 Define the Nearby Reference LevelsSector Neutral Pair - Vinanet
Rosen Law Firm investigates TransMedics Group f... - Pluang
Summit Creek Advisors LLC Takes $1.77 Million Position in TransMedics Group, Inc. $TMDX - MarketBeat
Q1 2026 Transmedics Group Inc Earnings Call Transcript - GuruFocus
Transmedics Group Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Q4 2025 Transmedics Group Inc Earnings Call Transcript - GuruFocus
TransMedics Targets $2B Opportunity With Kidney Push, European Expansion - Yahoo Finance
TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of ... - Caledonian Record
TransMedics Group, Inc. Investor News: Rosen Law Firm - GlobeNewswire
TransMedics (TMDX) director gifts 18,000 shares - Stock Titan
TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc.TMDX - Business Wire
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Morningstar
TransMedics Group, Inc. (TMDX) Stock Analysis: Unveiling Growth Potential with a 9.84% Upside - DirectorsTalk Interviews
TransMedics Group, Inc. $TMDX Shares Sold by Royal Bank of Canada - MarketBeat
Law firm investigates TransMedics officers for possible shareholder duty breaches - Pluang
TransMedics Group, Inc. (NASDAQ:TMDX) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
ETFs Investing in TransMedics Group, Inc. Stocks - TradingView
ChronicCareIQ Appoints Tom Visotsky as Chief Revenue Officer - AOL.com
Transmedics Group Stock Price Forecast. Should You Buy TMDX? - StockInvest.us
TransMedics (TMDX) Q2 2026 Earnings Call Transcript - AOL.com
symbol__ Stock Quote Price and Forecast - CNN
(TMDX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Wasatch Advisors LP Has $20.49 Million Stock Position in TransMedics Group, Inc. $TMDX - MarketBeat
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc.TMDX - Sahm
TMDX: Strong growth, new kidney program, and global expansion set stage for multi-billion revenue - TradingView
TransMedics Group, Inc. (TMDX) Stock Analysis: Healthcare Innovations with a 15.99% Upside Potential - DirectorsTalk Interviews
Why TransMedics Stock Is Sinking Today - AOL.com
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Microvast Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDX - GlobeNewswire Inc.
TransMedics Group Inc (TMDX) Stock Up 4.9% and Still Undervalued -- GF Score: 70/100 - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
TransMedics: Margins Down, Concentration Up, Trials Delayed - Seeking Alpha
TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc.TMDX - Sahm
Q2 2026 Transmedics Group Inc Earnings Call Transcript - GuruFocus
TransMedics Group (NASDAQ:TMDX) Price Target Lowered to $77.00 at UBS Group - MarketBeat
Why TransMedics Group (TMDX) Stock Is Down Today - Quiver Quantitative
TransMedics Stock Dips Post Q2 Earnings Miss, Margins Contract - Yahoo Finance
TransMedics Group (NASDAQ:TMDX) Shares Gap Down on Disappointing Earnings - MarketBeat
TransMedics Group, Inc. Stock 12‑Month Price Target Cut to $97.3, Implies 20% Upside - TradingView
TransMedics Group, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:TMDX) 2026-08-05 - Seeking Alpha
TransMedics Group (TMDX) Stock Looks Cheap On Earnings But Full After 171% Gain - Yahoo Finance
TransMedics Group Inc (TMDX) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
TransMedics Group Q2 Earnings Call Highlights - MarketBeat
Do TransMedics’ (TMDX) New Equity Grants And UBS Coverage Reveal A Shifting Growth Playbook? - webull.com
TransMedics Group (NASDAQ:TMDX) Posts Earnings Results, Misses Expectations By $0.06 EPS - MarketBeat
TransMedics (TMDX) Reports Q2 Earnings: What Key Metrics Have to Say - finance.yahoo.com
Earnings call transcript: TransMedics Q2 2026 revenue rises, but EPS misses - Investing.com
Is TransMedics Group Inc (TMDX) Undervalued After Q2 Earnings Mi - GuruFocus
TransMedics Group Q2 Adjusted Net Income Falls, Revenue Rises - marketscreener.com
TransMedics (TMDX) Q2 Earnings Lag Estimates - Yahoo Finance
Transmedics Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
TransMedics Group (TMDX) Stock Rises on Q2 2026 Earnings - Quiver Quantitative
Earnings Flash (TMDX) TransMedics Group, Inc. Reports Q2 Revenue $189.9M, vs. FactSet Est of $184.0M - marketscreener.com
Earnings Flash (TMDX) TransMedics Group, Inc. Posts Q2 Adjusted EPS $0.44 per Share, vs. FactSet Est of $0.47 - marketscreener.com
TransMedics Group, Inc. (TMDX) Q2 FY2026 earnings call transcript - Yahoo Finance
TransMedics Group, Inc. Q2 2026: Revenue $189.9M, EPS $0.41— 10-Q Summary - TradingView
TransMedics Group, Inc. Quarterly Earnings Report - Stock Titan
TransMedics Group posts Q2 2026 revenue $189.9M, net income $14.7M; raises FY26 revenue guide - TradingView
TransMedics raises low end of 2026 revenue guidance to $737M - Stock Titan
0.81%
0.02%
자본화:
|
볼륨(24시간):